Skip to main content

Malignant Testicular Neoplasm Clinical Trials

Review the malignant testicular neoplasm clinical trials on this list and use the filters to refine the results by age and location. Some clinical trials are held at NCI-Designated Cancer Centers and may be supported by other organizations.

You can find more information about the types and phases of clinical trials and what to expect or use our Steps to Find a Clinical Trial.

Trials 1-18 of 18

Active Surveillance, Bleomycin, Etoposide, Carboplatin or Cisplatin in Treating Pediatric and Adult Patients with Germ Cell Tumors
Status: Active
Location: 470 locations
Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients with High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy
Status: Active
Location: 198 locations
Accelerated or Standard BEP Chemotherapy in Treating Patients with Intermediate or Poor-Risk Metastatic Germ Cell Tumors
Status: Active
Location: 169 locations
Glofitamab plus Polatuzumab-R-CHP for the Treatment of High-Risk Diffuse Large B-Cell Lymphoma
Status: Active
Location: 4 locations
A Phase 1 Study of CTIM-76 in Patients With Recurring Ovarian Cancer and Other Advanced Solid Tumors
Status: Active
Location: 3 locations
Zanzalintinib in Combination with Oral Etoposide for the Treatment of Relapsed and Refractory Metastatic Germ Cell Tumors
Status: Active
Location: Indiana University/Melvin and Bren Simon Cancer Center, Indianapolis, Indiana
Integrative Medicine for the Improvement of Patient-Reported Outcomes, Values, and Experience
Status: Active
Location: 7 locations
A Study Comparing Music Therapy and Cognitive Behavioral Therapy for Anxiety in Cancer Survivors
Status: Active
Location: 3 locations
A Biobehavioral Intervention (GET) for the Reduction of Adverse Outcomes in Young Adult Testicular Cancer Survivors
Status: Active
Location: 2 locations
Symptom Management and Transitioning to Engagement with Post-treatment Care Intervention to Provide Developmentally Relevant Care for Adolescent and Young Adult Cancer Survivors, AYA STEPS Trial
Status: Active
Location: Duke University Medical Center, Durham, North Carolina
Low-Dose Aspirin for the Prevention of Venous Thromboembolism in Patients Receiving Chemotherapy for Testicular Cancer or Advanced Germ Cell Tumors, ASPIRE GCT Trial
Status: Active
Location: 2 locations
New PET Scan (68Ga-FAPI-46) for People with Cancers
Status: Active
Location: UCLA / Jonsson Comprehensive Cancer Center, Los Angeles, California
Evaluation of an Imaging Protocol to Identify Lymph Nodes and Organs of Interest in Patients with Urologic Cancer During Surgery
Status: Active
Location: Brigham and Women's Hospital, Boston, Massachusetts
Virtual Health Insurance Education Program (CHAT-S) for Improving Health Insurance Literacy and Surveillance in Young Adult Cancer Survivors
Status: Active
Location: 2 locations
A Virtual Support Platform to Improve Well-Being and Quality of Life in Men with Testicular Cancer, VITALSS Study - AIM 2
Status: Approved
Location: UNC Lineberger Comprehensive Cancer Center, Chapel Hill, North Carolina
A Study of Circulating Tumor DNA (ctDNA) Testing for People With B-Cell Lymphoma
Status: Active
Location: Memorial Sloan Kettering Cancer Center, New York, New York
Phase II Trial of Serum Micro RNA-371 in Detecting Active Germ Cell Tumors in Patients with Suspected Regional Disease - (MAGESTIC Trial: MiRNA in Detecting Active Germ Cell Tumors in Early Suspected and MetastaTIC Disease Trial)
Status: Temporarily Closed to Accrual
Location: 4 locations
Evaluation of 7 Tesla MRI Neuroimaging in Testicular Cancer Patients with Hypogonadism and on Androgen Replacement Therapy
Status: Temporarily Closed to Accrual
Location: 2 locations